Objectives: We wanted to re-evaluate the influence of confined placental mosaicism subtypes (type 2 and type 3) on pregnancy characteristics and outcome.
Material And Methods: From July 2009 to December 2015, 5512 chorionic villus samplings were performed in our Fetal Medicine Center. Conventional karyotyping was performed after long-term and short-term cultured villi to define type 2 or type 3 confined placental mosaicisms. Karyotype after amniocentesis was performed to exclude true fetal mosaicism, when appropriate. Pregnancy characteristics and outcomes were collected and compared to a control population.
Results: Thirty-six (0.65%) confined placental mosaicisms were observed (13 type 2 and 23 type 3). Nuchal translucency was not increased for type 2 and type 3 confined placental mosaicisms. Pregnancy characteristics and outcomes were comparable between type 2 confined placental mosaicisms and the control population. In type 3 confined placental mosaicisms, median first trimester serum pregnancy-associated plasma protein A was lower than for the control population (p<0.001), preterm births were noticed in 56% (p<0.001), small for gestational age newborns in 74% (p<0.001), and adverse pregnancy outcome was reported in 35% (p<0.01).
Conclusion: Although type 2 confined placental mosaicisms appeared to have no influence on pregnancy characteristics and outcome, type 3 confined placental mosaicisms were associated with low levels of first trimester serum pregnancy-associated plasma protein A, preterm birth, small for gestational age newborns, and adverse pregnancy outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897023 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0195905 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Peripartum Cesarean Hysterectomy for Placenta Percreta: A Retrospective Analysis of Cases With and Without Extrauterine Disease.
Cureus
October 2024
Department of Obstetrics and Gynecology, Mansoura University, Mansoura, EGY.
Article Synopsis
- The study aimed to compare maternal morbidity and prenatal characteristics between two groups of women with placenta percreta: those with extrauterine disease (group B) and those with disease confined to the uterus (group A).
- A total of 73 cases were analyzed, revealing significantly higher blood loss, injury rates, and complications in group B compared to group A, highlighting the increased risks associated with extrauterine disease.
- The findings suggest that specialized care for placenta accreta spectrum (PAS) is essential, as cases with extrauterine disease are more complex and lead to higher maternal morbidity, indicating a need for differentiation in treatment approaches.
β3-adrenergic agonist counters oxidative stress and Na-K pump inhibitory S-glutathionylation of placental cells: implications for preeclampsia.
Am J Physiol Cell Physiol
January 2025
Cellular Membrane Biology Group, Kolling Medical Research Institute, University of Sydney, New South Wales, Australia.
Oxidative stress from placental ischemia/reperfusion and hypoxia/reoxygenation (H/R) in preeclampsia is accompanied by Na-K pump inhibition and S-glutathionylation of its β1 subunit (GSS-β1), a modification that inhibits the pump. β3-adrenergic receptor (β3-AR) agonists can reverse GSS-β1. We examined the effects of the agonist CL316,243 on GSS-β1 and sources of H/R-induced oxidative stress in immortalized first-trimester human trophoblast (HTR-8/SVneo) and freshly isolated placental explants from normal-term pregnancies.
View Article and Find Full Text PDFHarnessing the Therapeutic Potential of Mesenchymal Stem Cells in Cancer Treatment.
Adv Pharm Bull
October 2024
Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Article Synopsis
- * Mesenchymal stem cells (MSCs), which can be sourced from tissues like bone marrow and adipose, have unique properties that make them promising for cancer treatment, including their ability to differentiate into various cell types and target tumors.
- * MSCs and their exosomes show potential in delivering therapeutic agents and inhibiting cancer progression by disrupting key signaling pathways, but challenges remain in effectively utilizing them in therapies.
Associations between term cesarean delivery in the first pregnancy and second-pregnancy preterm delivery.
Acta Obstet Gynecol Scand
October 2024
Department of Clinical Science, University of Bergen, Bergen, Norway.
Introduction: Cesarean delivery has been shown to increase the risk of preterm delivery in future pregnancies. The association could be a direct result of the procedure, or because the indications that led to the cesarean delivery also increase the risk of preterm delivery in later pregnancies.
Material And Methods: 298 901 mothers with first and second singleton deliveries from 1999 to 2020 were investigated using data from the Medical Birth Registry of Norway linked with Statistics Norway.
COVID-19 Vaccine mRNA Biodistribution: Maternal and Fetal Exposure Risks.
Am J Reprod Immunol
October 2024
Women and Children's Research Laboratory, Departments of Foundations of Medicine, New York University-Grossman Long Island School of Medicine, Mineola, New York, USA.
Article Synopsis
- SARS-CoV-2 infection during pregnancy can have serious consequences for both mothers and newborns, making vaccination a crucial preventative tool.
- Early clinical trials did not include pregnant women, but later studies confirmed the effectiveness and short-term safety of mRNA vaccines in this group.
- There is limited information on how vaccine mRNA spreads during pregnancy and breastfeeding, with new evidence showing it's present in breast milk, raising concerns about its potential impact on the placenta and fetus that need further exploration.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!